Cardiovascular Diabetology | Most Viewed

Submit a manuscript Register Contact us Follow
BioMed Central Support

Explore journal

Advertisement

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	51. 8959 Accesses	Original investigation Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population N Al-Daghri, R Chetty, PG McTernan, K Al-Rubean, O Al-Attas, AF Jones, S Kumar Cardiovascular Diabetology 2005, 4:10 (5 July 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	52. 8847 Accesses	Original investigation Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes Li Pu, Lin Lu, Xue Xu, Rui Zhang, Qi Zhang, Jian Zhang, Jian Hu, Zheng Yang, Feng Ding, Qiu Chen, Sheng Lou, Jie Shen, Dan Fang, Wei Shen Cardiovascular Diabetology 2006, 5:27 (20 December 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	53. 8738 Accesses	Original investigation Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development Srinivasan Kumar, S Thameem Dheen, Samuel Tay Cardiovascular Diabetology 2007, 6:34 (30 October 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	54. 8723 Accesses	Original investigation Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction Hongmei Chen, Sachin Brahmbhatt, Akanksha Gupta, Avadhesh C Sharma Cardiovascular Diabetology 2005, 4:3 (5 March 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	55. 8703 Accesses	Original investigation Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome Alireza Esteghamati, Mehrshad Abbasi, Manouchehr Nakhjavani, Abbas Yousefizadeh, Amelita P Basa, Hamid Afshar Cardiovascular Diabetology 2006, 5:15 (17 July 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	56. 8702 Accesses	Hypothesis Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof Enrique Z Fisman, Michael Motro, Alexander Tenenbaum Cardiovascular Diabetology 2003, 2:11 (12 September 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	57. 8666 Accesses	Original investigation Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study Jøran Hjelmesæth, Dag Hofsø, Erlend T Aasheim, Trond Jenssen, Johan Moan, Helle Hager, Jo Røislien, Jens Bollerslev Cardiovascular Diabetology 2009, 8:7 (3 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	58. 8443 Accesses	Original investigation Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study Jorge Escobedo, Herman Schargrodsky, Beatriz Champagne, Honorio Silva, Carlos P Boissonnet, Raul Vinueza, Marta Torres, Rafael Hernandez, Elinor Wilson Cardiovascular Diabetology 2009, 8:52 (26 September 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	59. 8396 Accesses	Review Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data Michael E Cobble, Robert Frederich Cardiovascular Diabetology 2012, 11:6 (16 January 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	60. 8279 Accesses	Review Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes Markolf Hanefeld Cardiovascular Diabetology 2007, 6:20 (15 August 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	61. 8270 Accesses	Review Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins Sameer Ansar, Juraj Koska, Peter D Reaven Cardiovascular Diabetology 2011, 10:61 (7 July 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	62. 8232 Accesses	Original investigation Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study David J Leehey, Irfan Moinuddin, Joseph P Bast, Shahzad Qureshi, Christine S Jelinek, Cheryl Cooper, Lonnie C Edwards, Bridget M Smith, Eileen G Collins Cardiovascular Diabetology 2009, 8:62 (9 December 2009) Abstract \| Full text \| PDF \| PubMed
	63. 8185 Accesses	Review Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis Sonia Butalia, Alexander A Leung, William A Ghali, Doreen M Rabi Cardiovascular Diabetology 2011, 10:25 (1 April 2011) Abstract \| Full text \| PDF \| PubMed
	64. 7813 Accesses	Original investigation Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model Ariel Roguin, Samy Nitecki, Irit Rubinstein, Eviatar Nevo, Aaron Avivi, Nina S Levy, Zaid A Abassi, Edmond Sabo, Orit Lache, Meira Frank, Aaron Hoffman, Andrew P Levy Cardiovascular Diabetology 2003, 2:18 (18 December 2003) Abstract \| Full text \| PDF \| PubMed \| 1 comment
	65. 7813 Accesses	Hypothesis Neurohumoral stimulation in type-2-diabetes as an emerging disease concept RU Pliquett, M Fasshauer, M Blüher, R Paschke Cardiovascular Diabetology 2004, 3:4 (17 March 2004) Abstract \| Full text \| PDF \| PubMed
	66. 7747 Accesses	Original investigation High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study Mats CE Eliasson, Jan-Håkan Jansson, Bernt Lindahl, Birgitta Stegmayr Cardiovascular Diabetology 2003, 2:19 (22 December 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	67. 7677 Accesses	Original investigation Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults Toshitaka Muneyuki, Kei Nakajima, Atsushi Aoki, Masashi Yoshida, Hiroshi Fuchigami, Hiromi Munakata, San-e Ishikawa, Hitoshi Sugawara, Masanobu Kawakami, Shin-ichi Momomura, Masafumi Kakei Cardiovascular Diabetology 2012, 11:80 (29 June 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	68. 7629 Accesses	Original investigation Blood pressure control and components of the metabolic syndrome: the GOOD survey Walter Zidek, Lisa Naditch-Brûlé, Stefano Perlini, Csaba Farsang, Sverre E Kjeldsen Cardiovascular Diabetology 2009, 8:51 (15 September 2009) Abstract \| Full text \| PDF \| PubMed \| 1 comment
	69. 7558 Accesses	Original investigation Monocyte matrix metalloproteinase production in Type 2 diabetes and controls – a cross sectional study Mark D Baugh, Jelena Gavrilovic, Isabel R Davies, David A Hughes, Mike J Sampson Cardiovascular Diabetology 2003, 2:3 (10 March 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	70. 7544 Accesses	Original investigation Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study Anne Gill, Byron J Hoogwerf, Jude Burger, Simon Bruce, Leigh MacConell, Ping Yan, Daniel Braun, Joseph Giaconia, James Malone Cardiovascular Diabetology 2010, 9:6 (28 January 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	71. 7543 Accesses	Original investigation Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study) Michel Komajda, Paula Curtis, Markolf Hanefeld, Henning Beck-Nielsen, Stuart J Pocock, Andrew Zambanini, Nigel P Jones, Ramon Gomis, Philip D Home, The RECORD Study Group Cardiovascular Diabetology 2008, 7:10 (24 April 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	72. 7445 Accesses	Review YKL-40 - an emerging biomarker in cardiovascular disease and diabetes Camilla N Rathcke, Henrik Vestergaard Cardiovascular Diabetology 2009, 8:61 (23 November 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	73. 7430 Accesses	Original investigation Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products Philipp Ehlermann, Kai Eggers, Angelika Bierhaus, Patrick Most, Dieter Weichenhan, Johannes Greten, Peter P Nawroth, Hugo A Katus, Andrew Remppis Cardiovascular Diabetology 2006, 5:6 (30 March 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	74. 7402 Accesses	Original investigation Saturated free fatty acids and apoptosis in microvascular mesangial cells: palmitate activates pro-apoptotic signaling involving caspase 9 and mitochondrial release of endonuclease G Rangnath Mishra, Michael S Simonson Cardiovascular Diabetology 2005, 4:2 (10 January 2005) Abstract \| Full text \| PDF \| PubMed
	75. 7394 Accesses	Original investigation Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders Wilfried Dinh, Reiner Füth, Werner Nickl, Thomas Krahn, Peter Ellinghaus, Thomas Scheffold, Lars Bansemir, Alexander Bufe, Michael Coll Barroso, Mark Lankisch Cardiovascular Diabetology 2009, 8:58 (12 November 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	76. 7345 Accesses	Hypothesis Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists? Osman ABSM Gani Cardiovascular Diabetology 2008, 7:6 (20 March 2008) Abstract \| Full text \| PDF \| PubMed
	77. 7316 Accesses	Original investigation Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil Ulrich Dietz, Hans-Peter Tries, Walter Merkle, Cornelia Jaursch-Hancke, Heinz Lambertz Cardiovascular Diabetology 2003, 2:8 (4 August 2003) Abstract \| Full text \| PDF \| PubMed
	78. 7275 Accesses	Editorial Statins research unfinished saga: desirability versus feasibility Enrique Z Fisman, Yehuda Adler, Alexander Tenenbaum Cardiovascular Diabetology 2005, 4:8 (7 June 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	79. 7194 Accesses	Study protocol Walking behaviour and glycemic control in type 2 diabetes: seasonal and gender differences-Study design and methods Kaberi Dasgupta, Cathy Chan, Deborah Da Costa, Louise Pilote, Mirella De Civita, Nancy Ross, Ian Strachan, Ronald Sigal, Lawrence Joseph Cardiovascular Diabetology 2007, 6:1 (15 January 2007) Abstract \| Full text \| PDF \| PubMed
	80. 7174 Accesses	Case Report Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient Philippe Woods, Carmen Paquette, Julie Martin, Jean-Gaston Dumesnil, Picard Marceau, Simon Marceau, Simon Biron, Frédéric Hould, Odette Lescelleur, Stéphane Lebel, Paul Poirier Cardiovascular Diabetology 2004, 3:5 (27 April 2004) Abstract \| Full text \| PDF \| PubMed
	81. 7130 Accesses	Original investigation Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes Robert Ratner, Jenny Han, Dawn Nicewarner, Irina Yushmanova, Byron J Hoogwerf, Larry Shen Cardiovascular Diabetology 2011, 10:22 (16 March 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	82. 7023 Accesses	Original investigation Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone Sean D Sullivan, Rafael Alfonso-Cristancho, Chris Conner, Mette Hammer, Lawrence Blonde Cardiovascular Diabetology 2009, 8:12 (26 February 2009) Abstract \| Full text \| PDF \| PubMed
	83. 7009 Accesses	Original investigation Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease Minako Yamaoka-Tojo, Taiki Tojo, Naonobu Takahira, Atsuhiko Matsunaga, Naoyoshi Aoyama, Takashi Masuda, Tohru Izumi Cardiovascular Diabetology 2010, 9:17 (14 May 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	84. 6983 Accesses	Original investigation Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging Rajprasad Loganathan, Mehmet Bilgen, Baraa Al-Hafez, Mohammed D Alenezy, Irina V Smirnova Cardiovascular Diabetology 2006, 5:7 (4 April 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	85. 6978 Accesses	Original investigation Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study) Gianluca Bardini, Carlo B Giorda, Antonio E Pontiroli, Cristina Le Grazie, Carlo M Rotella Cardiovascular Diabetology 2010, 9:20 (21 May 2010) Abstract \| Full text \| PDF \| PubMed
	86. 6966 Accesses	Original investigation Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease Hillary A Tuttle, Grace Davis-Gorman, Steven Goldman, Jack G Copeland, Paul F McDonagh Cardiovascular Diabetology 2003, 2:12 (4 October 2003) Abstract \| Full text \| PDF \| PubMed
	87. 6936 Accesses	Original investigation Endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor Juying Han, Anil K Mandal, Linda M Hiebert Cardiovascular Diabetology 2005, 4:12 (9 August 2005) Abstract \| Full text \| PDF \| PubMed
	88. 6848 Accesses	Hypothesis The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes Raffaele Marfella, Michele D' Amico, Clara Di Filippo, Mario Siniscalchi, Ferdinando sasso, Franca Ferraraccio, Francesco Rossi, Giuseppe Paolisso Cardiovascular Diabetology 2007, 6:35 (30 October 2007) Abstract \| Full text \| PDF \| PubMed
	89. 6779 Accesses	Original investigation Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: Relation to vessel size WeiWei Song, Adviye Ergul Cardiovascular Diabetology 2006, 5:3 (17 February 2006) Abstract \| Full text \| PDF \| PubMed
	90. 6773 Accesses	Original investigation Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat Fabien Forcheron, Alexandra Basset, Pauline Abdallah, Peggy Del Carmine, Nicolas Gadot, Michel Beylot Cardiovascular Diabetology 2009, 8:16 (24 March 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	91. 6747 Accesses	Original investigation Novel adiponectin-resistin (AR) and insulin resistance (IR_AR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study Cia-Hin Lau, Sekaran Muniandy Cardiovascular Diabetology 2011, 10:8 (21 January 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	92. 6747 Accesses	Original investigation Hyperglycemia and nocturnal systolic blood pressure are associatedwith left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients João S Felício, Juliana T Pacheco, Sandra R Ferreira, Frida Plavnik, Valdir A Moisés, Oswaldo Kohlmann, Artur B Ribeiro, Maria T Zanella Cardiovascular Diabetology 2006, 5:19 (12 September 2006) Abstract \| Full text \| PDF \| PubMed \| 1 comment
	93. 6743 Accesses	Original investigation Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state A Gruber, F Horwood, J Sithole, NJ Ali, I Idris Cardiovascular Diabetology 2006, 5:22 (1 November 2006) Abstract \| Full text \| PDF \| PubMed
	94. 6718 Accesses	Original investigation Elevated resting heart rate is associated with the metabolic syndrome Ori Rogowski, Arie Steinvil, Shlomo Berliner, Michael Cohen, Nili Saar, Orit Kliuk Ben-Bassat, Itzhak Shapira Cardiovascular Diabetology 2009, 8:55 (14 October 2009) Abstract \| Full text \| PDF \| PubMed
	95. 6700 Accesses	Methodology Maximal exercise test is a useful method for physical capacity and oxygen consumption determination in streptozotocin-diabetic rats Bruno Rodrigues, Diego M Figueroa, Cristiano T Mostarda, Marcelo V Heeren, Maria-Cláudia Irigoyen, Kátia De Angelis Cardiovascular Diabetology 2007, 6:38 (13 December 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	96. 6691 Accesses	Study protocol The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 × 2 factorial understanding risk trial Hermione C Price, Lynne Tucker, Simon J Griffin, Rury R Holman Cardiovascular Diabetology 2008, 7:21 (17 July 2008) Abstract \| Full text \| PDF \| PubMed
	97. 6666 Accesses	Methodology Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines Cory Russell, Peggy Dunbar, Sonia Salisbury, Ingrid Sketris, George Kephart Cardiovascular Diabetology 2005, 4:11 (20 July 2005) Abstract \| Full text \| PDF \| PubMed
	98. 6640 Accesses	Original investigation Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries Alison M Gurney, Frank C Howarth Cardiovascular Diabetology 2009, 8:4 (21 January 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	99. 6623 Accesses	Original investigation Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study Sarita Dhuper, Hillel W Cohen, Josephine Daniel, Padmasree Gumidyala, Vipin Agarwalla, Rosemarie St Victor, Sunil Dhuper Cardiovascular Diabetology 2007, 6:4 (14 February 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	100. 6571 Accesses	Review Pharmacological and non-pharmacological interventions to influence adipose tissue function Jan Westerink, Frank LJ Visseren Cardiovascular Diabetology 2011, 10:13 (28 January 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central